BONEX.ST WACC - Weighted Average Cost of Capital
The WACC of Bonesupport Holding AB (BONEX.ST) is 6.4%.
| Range | Selected | |
| Cost of equity | 5.1% - 7.7% | 6.4% |
| Tax rate | 5.0% - 12.2% | 8.6% |
| Cost of debt | 4.0% - 10.8% | 7.4% |
| WACC | 5.1% - 7.7% | 6.4% |
| Category | Low | High |
| Long-term bond rate | 2.5% | 3.0% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.41 | 0.61 |
| Additional risk adjustments | 0.5% | 1.0% |
| Cost of equity | 5.1% | 7.7% |
| Tax rate | 5.0% | 12.2% |
| Debt/Equity ratio | 0 | 0 |
| Cost of debt | 4.0% | 10.8% |
| After-tax WACC | 5.1% | 7.7% |
| Selected WACC | 6.4% | |
| Debt/Equity | Unlevered | |||
| Peers | Company Name | ratio | Beta | beta |
| BONEX.ST | Bonesupport Holding AB | 0 | 0.03 | 0.03 |
| ALERS.PA | Eurobio Scientific SA | 0.39 | -0.49 | -0.36 |
| ALPHA.PA | Pharnext SA | 19402.47 | -0.69 | 0 |
| AZT.OL | Arcticzymes Technologies ASA | 0.01 | 0.48 | 0.48 |
| B8F.DE | Biofrontera AG | 1.3 | 0.33 | 0.15 |
| BML.WA | Biomed Lublin Wytwornia Surowic i Szczepionek SA | 0.04 | 0.41 | 0.4 |
| DBV.PA | DBV Technologies SA | 0.03 | 0.54 | 0.53 |
| HBC.OL | Hofseth Biocare ASA | 0.16 | 0.52 | 0.45 |
| PROB.ST | Probi AB | 0.15 | 0.1 | 0.09 |
| TNG.PA | Transgene SA | 0.02 | 0.94 | 0.93 |
| Low | High | |
| Unlevered beta | 0.13 | 0.42 |
| Relevered beta | 0.12 | 0.42 |
| Adjusted relevered beta | 0.41 | 0.61 |
BONEX.ST's CAPM model and how its cost of Equity is calculated
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for BONEX.ST:
cost_of_equity (6.40%) = risk_free_rate (2.75%) + equity_risk_premium (5.60%) * adjusted_beta (0.41) + risk_adjustments (0.75%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.